课题基金 / 基金详情

项目摘要

项目成果

ANDREW D BADLEY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): It remains controversial as to how CD4+ T cells directly infected with HIV die following infection. Numerous mechanisms have been proposed to account for infected cell killing, however none of the proposed mechanisms are universally accepted. It has long been recognized that one HIV protein, HIV protease, is intrinsically cytotoxic as its expression causes the death of bacteria, yeast, and mammalian cells, however it remains unclear how HIV protease kills these cells. Experimental data now demonstrate that HIV protease cleaves host cell proteins in addition to viral proteins. Our laboratory has recently defined one mechanism by which HIV protease can kill cells; specifically HIV protease can cleave the apoptosis initiating protein, procaspase 8, to result in its activation. Thereafter, a traditional apoptosis cascade is initiated, ultimately resulting in the structural, nuclear, and morphologic changes associated with apoptosis. While we have demonstrated that this mechanism of HIV protease mediated killing can occur, we have yet to determine whether or not this mechanism does occur, particularly in vivo. The focus of the current proposal is to define the relevance of this form of cell killing both in infections, which occur in the test tube, as well as in patients. The clinical significance of this research may be reflected in recent clinical observations, suggesting an altered diseased course of patients who have infections with HIV that contain mutations within the HIV protease gene as compared to those that do not. We will explore the potential impact of these mutations by assessing the differential impact of wild type HIV protease versus mutant protease on procaspase 8 activation and cell killing.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Beneficial effect of TRAIL on HIV burden, without detectable immune consequences.
TRAIL 对 HIV 负担具有有益作用,且没有可检测到的免疫后果。
DOI: 10.1371/journal.pone.0003096
发表时间: 2008
期刊: PloS one
影响因子: 3.7
作者: [Shepard,BrettD, DeForni,Davide, McNamara,DavidR, Foli,Andrea, Rizza,StaceyA, Abraham,RoshiniS, Knutson,Keith, Wettstein,PeterJ, Lori,Franco, Badley,AndrewD]
通讯作者: Badley,AndrewD
TRAIL dependent fratricidal killing of gp120 primed hepatocytes by HCV core expressing hepatocytes.
表达 HCV 核心的肝细胞对 gp120 引发的肝细胞进行 TRAIL 依赖性自相残杀。
DOI: 10.1371/journal.pone.0027171
发表时间: 2011
期刊: PloS one
影响因子: 3.7
作者: [Rizza,StaceyA, Challagundla,KishoreB, Natesampillai,Sekar, Bren,GaryD, Sykora,Jaromir, Walczak,Henning, Badley,AndrewD]
通讯作者: Badley,AndrewD
Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence.
  • 批准号:
    9272805
  • 项目类别:
  • 资助金额:
    $50.57万
  • 财政年份:
    2015
  • 负责人:
    ANDREW D BADLEY
  • 依托单位:
Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence.
  • 批准号:
    8990167
  • 项目类别:
  • 资助金额:
    $50.57万
  • 财政年份:
    2015
  • 负责人:
    ANDREW D BADLEY
  • 依托单位:
Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence.
  • 批准号:
    9089882
  • 项目类别:
  • 资助金额:
    $50.57万
  • 财政年份:
    2015
  • 负责人:
    ANDREW D BADLEY
  • 依托单位:
Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence
  • 批准号:
    10427482
  • 项目类别:
  • 资助金额:
    $60.69万
  • 财政年份:
    2015
  • 负责人:
    ANDREW D BADLEY
  • 依托单位:
海外基金